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Elevated uric acid levels are associated with risk factors
common to patients who require coronary artery bypass graft
(CABG) surgery. In this edition of the Journal, Hills and
coworkers now propose that hyperuricemia may also be an
independent risk factor for adverse events after CABG
surgery.1 In this single-center, retrospective series, the authors
have shown that patients with hyperuricemia undergoing
isolated, nonemergency surgery have a higher incidence of
mortality over a 3-year period. Hyperuricemia has been as-
sociated with adverse cardiovascular events in patients
with atherosclerotic disease.2 Furthermore, it has been
shown that cardiovascular events are decreased in patients
undergoing CABG who receive allopurinol in the perioper-
ative period.3 Thus, this study would be novel if the authors
showed that in a group of patients undergoing cardiac
surgery with optimal perioperative care, hyperuricemia still
emerged as a marker of increased long-term cardiovascular
mortality. Unfortunately, the authors have not provided us
with that data.
Patients with hyperuricemia were more likely to be older,
to have worse renal function, to be obese, to have reduced
ejection fraction, and to have higher Euroscores. All of these
factors are associated with reduced long-term survival after
CABG surgery. The incidence of diabetes mellitus in this
series was relatively low, only 11%, suggesting that this dis-
ease may have been undiagnosed. Studies have shown that
undiagnosed diabetes mellitus is a significant predictor of
decreased survival 1 year after CABG.4 Could it be that
a significant number of these patients with hyperuricemia
actually had diabetes mellitus? We are not told about
perioperative glucose and glycosylated hemoglobin values.
Furthermore, there was no formal protocol to maintain
glycemic control during the perioperative period.
No data are provided regarding the perioperative use of
beta-blockers, statins, and angiotensin enzyme inhibitors,
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cemia has been associated with hypercholesterolemia, which
results in decreased graft patency and increased cardio-
vascular events.5 The underuse of statins could easily have
accounted for the poor long-term outcomes in the patients
with hyperuricemia. Furthermore, we are not told how
many patients with hyperuricemia had a diagnosis of gout
preoperatively and how many actually received allopurinol
before or after surgery. The exact causes of death are not pro-
vided, and the sample size is limited such that only univari-
ate analyses could be performed.
We are still left wondering whether it is the elevated uric
acid levels or the comorbidities associated with them that are
responsible for the poor long-term survival. Furthermore,
because the high uric acid levels were not appropriately
treated, we have no idea as to whether survival could be im-
proved if these patients were properly treated with allopuri-
nol. The answer to these questions can only be provided
from a larger cohort of patients who receive appropriate ther-
apy for hyperuricemia, as well as for diabetes and hypercho-
lesterolemia. Until then, in patients with hyperuricemia after
CABG surgery, we are left to wonder, is it the chicken or the
egg?
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